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ABSTRACT 36 
Background: Establishing the amount of inpatient physical activity (PA) undertaken by 37 
individuals hospitalised for chronic respiratory disease is needed to inform interventions. This 38 
observational study investigated whether PA changes as an inpatient, how long is required to 39 
obtain representative PA measures, and whether PA varies within a day and between patients 40 
of differing lengths of stay. 41 
Methods: 389 participants were recruited as early as possible into their hospitalisation. 42 
Patients wore a PA monitor from recruitment until discharge. Step count was extracted for a 43 
range of wear time criteria. Single-day intraclass correlation coefficients (ICCs) were 44 
calculated with an ICC ≥0.80 deemed acceptable. 45 
Results: PA data were available in 259 participants. No changes in daily step count were 46 
observed during the inpatient stay (586 [95%CI 427-744] vs. 652 [95%CI 493-812] steps/day 47 
for day 2 and 7, respectively). ICCs across all wear time criteria were >0.80. The most 48 
stringent wear time criterion retaining 80% of the sample was ≥11 hours on ≥1 days. More 49 
steps were taken during the morning and afternoon than overnight and evening. After 50 
controlling for MRC grade or oxygen use, there was no difference in step count between 51 
patients admitted for 2-3 days (short-stay) and those admitted for 7-14 days (long-stay).  52 
Conclusion: Inpatient PA did not increase during hospitalisation. A wear time criterion of 11 53 
waking hours on any single day was representative of the entire hospital stay whilst retaining 54 
an acceptable proportion of the initial sample size. Patients should be encouraged to move 55 
more during their hospital stay.  56 
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INTRODUCTION 57 
Physical activity (PA) is a complex behaviour typically defined as “any bodily movement 58 
produced by skeletal muscle which results in caloric expenditure”.1 Patients with respiratory 59 
disease are less physically active than healthy counterparts
2
 and other populations with long-60 
term conditions.
3
 A lack of sufficient PA has been independently associated with all-cause 61 
mortality
4
 and hospitalisation
5
 in stable patients and readmission for patients recently 62 
experiencing an acute exacerbation of chronic obstructive pulmonary disease (COPD).
6
  63 
Hospitalisation for an exacerbation is an important event in the history of COPD, with high 64 
rates of readmission and death.
7
 Exacerbations also have considerable impact on the whole 65 
body, increasing risk of future events.
8,9
 Hospital bed rest has also been associated with 66 
muscle atrophy and thromboembolic disease.
10
 Establishing the volume and pattern of PA 67 
during the hospital stay is needed to inform inpatient and reablement interventions. 68 
The need to get patients moving more in hospital has long been advocated
11
 but PA  remains 69 
low, with inpatients spending approximately 87% of time lying down, minimal improvement 70 
seen during the stay and patients remaining inactive after discharge.
12-14
 However, 71 
conclusions are limited due to small sample sizes in reported studies and heterogeneity in PA 72 
data processing; including how many days and for how long each day individuals are 73 
required to wear an activity monitor in order to obtain representative data. Validated activity 74 
monitors such as the SenseWear Armband
15
, measuring not only movement, but also 75 
physiological parameters, offer an opportunity to understand the impact of wear adherence on 76 
the representativeness of PA data by automatically detecting whether or not the device is 77 
being worn.  78 
Objective assessments of PA using accelerometry for patients in the stable state are well 79 
accepted. A minimum of 4 days of at least 8 waking hours are recommended criteria to 80 
examine free-living PA for individuals with stable COPD.
16
 However, it is unclear whether 81 
these criteria would be appropriate for measuring inpatient PA. The hospital environment 82 
does not mimic free-living conditions; potentially restricting walking to a greater extent than 83 
at home
12
 and may reduce day-to-day variability in PA. Additionally, in free-living studies, 84 
participants commonly wear a monitor for a fixed number of days but the number of days 85 
people are hospitalised varies
17
 rendering this approach unsuitable. 86 
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This study aimed to; (i) determine the variability of PA during inpatient stay for an 87 
exacerbation of chronic respiratory disease and minimum wear requirement to be 88 
representative of the hospital stay; and (ii) measure how PA changes during inpatient 89 
recovery. It was hypothesised that inpatient PA would be less variable than free-living 90 
studies, resulting in fewer days required to obtain data representative of the hospital stay. In 91 
addition, it was hypothesised that there would be no change in PA as an inpatient. 92 
Exploratory analyses were conducted to examine how PA varies within a day and between 93 
patients of differing lengths of hospital stay.  94 
MATERIAL AND METHODS 95 
Study subjects 96 
Inpatient PA was obtained as part of an early rehabilitation trial previously reported.
18
 This 97 
was approved by the National Research Ethics Service Nottingham committee and all 98 
participants provided written informed consent. 389 participants were recruited to the study 99 
as early as possible into hospital admission and randomised to usual care or early 100 
rehabilitation. Early rehabilitation comprised supervised strength, aerobic training and 101 
neuromuscular electrical stimulation. Additionally, all patients received standard ward-based 102 
physiotherapy, including assessment and supervision of mobility. Inclusion criteria were age 103 
≥40 years; diagnosis of chronic respiratory disease; and Medical Research Council (MRC) 104 
dyspnoea grade ≥3 when stable. Exclusion criteria included concomitant acute cardiac event; 105 
presence of comorbidities preventing the delivery of early rehabilitation; and >4 emergency 106 
hospital admissions in previous 12 months. Activity monitors were removed during the 107 
additional rehabilitation intervention, so not to influence habitual PA. For this study, groups 108 
were pooled as there was no significant difference in PA between control and rehabilitation 109 
groups (mean±SD 657±712 vs. 577±582 steps/day, p=0.323). 110 
Methods 111 
Physical activity 112 
PA was measured using the SenseWear Armband (SWA) Pro 3, worn as per manufacturer 113 
recommendations. Patients were asked to wear the monitor continuously from recruitment 114 
until their date of discharge. Data from the SWA was processed in 60-second epochs. Periods 115 
of non-wear were determined by the SWA failing to detect physiological signals. Waking 116 
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wear time was then extracted by removing time in SWA-detected sleep. Step count was 117 
extracted for each day the device was worn for at least one hour.  118 
The first full 24-hour period of PA onwards was used for the analyses. Daily summaries for 119 
step count were created for minimum wear time criteria of  ≥1 hour to ≥12 hours in 120 
increments of one hour. Acceptable sample retention was deemed 80%. Change in PA was 121 
assessed across inpatient days (day 2 to day 7 after recruitment) and variability in step count 122 
within the day was examined using hourly summaries. PA was compared between patients of 123 
differing lengths of hospital stay: short-stay (2-3 days), medium-stay (4-6 days) and long-stay 124 
(7-14 days). 125 
Additional measures 126 
Lung function was measured by spirometry performed to national standards.
19
 Self-reported 127 
dyspnoea was obtained upon admission and reported retrospectively (during stable disease) 128 
using the MRC dyspnoea scale.
20 
129 
Analysis 130 
Descriptive data are presented as mean (SD) for continuous data. Pearson correlations were 131 
used to examine associations between continuous data. Repeated measures ANCOVA 132 
(waking wear time) were used to compare between days and between hours of the day. 133 
Greenhouse-Geisser adjusted F was used to determine statistical significance. For a 134 
significant F, post-hoc Bonferroni pairwise comparisons were used to identify differences 135 
between individual days or hours. ANCOVA was conducted to compare average step count 136 
between length of stay groups. Single-day intraclass correlation coefficients (ICCs; two-way 137 
mixed; consistency) were calculated across the range of wear time criteria. The minimum 138 
number of days required to obtain representative inpatient activity data (i.e. an ICC of 0.80)
21
 139 
was estimated using the Spearman-Brown prophecy formula.
22,23
 Analyses were conducted 140 
using SPSS 23 with alpha set to 0.05. 141 
RESULTS 142 
Study recruitment 143 
Inpatient PA data were available in 259 participants (67% of the total sample) (Figure 1), 144 
with a total of 1,393 days in hospital (mean±SD 5.4±3.1 days per person) of which 1,202 145 
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days (86.3%) had inpatient PA data (4.6±2.8 days per person). On average, patients wore the 146 
activity monitor each day during waking hours for 14.3±4.9 hours.  147 
Patients included in the present study were significantly younger than patients excluded 148 
(70.0±9.7 vs. 73.5±9.2 years, p=0.001). No other differences in participant characteristics 149 
were observed between patients included or excluded from the original cohort. 150 
Reasons for data not being available were; patients being discharged on the day of consent, 151 
not wearing the monitor and device malfunctions. 15 participants were excluded from 152 
analyses due to being admitted for more than 14 days.  153 
Participant characteristics 154 
Participant characteristics are provided in Table 1. Patients took a mean of 616±649 155 
steps/day. Average daily step counts across the range of minimum wear time criteria are 156 
provided in Table S1. Patients receiving oxygen took fewer steps than those not (617 [95%CI 157 
491-744] vs. 1058 [95%CI 848-1270] steps/day, p=0.001). 158 
Changes in step count during the hospital stay 159 
No significant changes in step count were observed between days during the inpatient stay 160 
(586 [95%CI 427-744] vs. 652 [95%CI 493-812] steps/day for days 2 and 7, respectively) 161 
(Table 2, Figure 2); and findings were unchanged after controlling for wear time. Across all 162 
wear time criteria, a single day of activity monitor data was sufficient to provide 163 
representative inpatient PA data. ICCs for step count across all wear time criteria were higher 164 
than 0.80; demonstrating that >80% of variance for PA was accounted for using any single 165 
day during hospital stay. Pairwise ICCs between days also revealed low variability in daily 166 
step count (ICC 0.669-0.907). 167 
Impact of wear time and valid day criteria on sample size 168 
The more hours a patient wears an activity monitor, the more representative the data. 169 
However, increasing the number of hours or days required to be considered a valid file will 170 
sample size retention. Using an 80% acceptable retention threshold, the most stringent criteria 171 
were ≥11 hours on ≥1 day and ≥7 hours on ≥2 days (Table S2). Given that a single day is 172 
representative of a patient’s inpatient stay, a minimum wear time of ≥11 hours on ≥1 day was 173 
used as the processing criteria for data presented from this point onwards. 174 
  175 
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Accumulation of steps during a day in hospital 176 
The pattern for step count during an average hospital day was examined by dividing the day 177 
into six hour slots (overnight, morning, afternoon and evening. Significant differences in the 178 
proportion of total daily step count were observed between quarters of the day (p<0.001) 179 
except between morning and afternoon (Figure 3). 50% of total daily steps were taken by 180 
13:00 and 75% by 18:00.  181 
Physical activity between patients of differing lengths of hospital stay 182 
Patients admitted for 7-14 days (long stay; N=89) reported a higher MRC grade (p=0.006) 183 
and greater use of oxygen (p=0.047) during admission than patients admitted for 2-3 days 184 
(short stay; N=93). Short stay patient took more steps per day than long stay patients (956 185 
[95%CI 734-1179] vs. 565 (95%CI 386-744]) but this difference was no longer present after 186 
controlling for MRC grade and oxygen use (p=0.368).  187 
DISCUSSION 188 
This study reports the largest cohort to date for the objective assessment of inpatient PA in 189 
patients admitted with an exacerbation of chronic respiratory disease, capturing more than 190 
85% of inpatient days. PA did not increase during their hospital stay and the number of steps 191 
taken by patients was much lower than would be expected during free-living periods of stable 192 
disease. A minimum of 11 waking hours on any single inpatient day was representative of the 193 
entire hospital stay whilst retaining an acceptable proportion of patients recruited. PA varied 194 
considerably within a typical day, with peaks of activity seen in the late morning and early 195 
afternoon. PA did not differ between patients of varying lengths of hospital stay.  196 
PA did not increase during hospital stay, demonstrating that recovery does not immediately 197 
translate into more walking. This observation aligns with Pitta and colleagues
12
 who found no 198 
difference between day 2 and day 7 of hospitalisation in 17 individuals with COPD. Daily 199 
step count observed in the present study (616±649 steps/day) was lower than previously 200 
reported (1557±1319 steps/day)
24
. Regardless, physical inactivity of patients during an 201 
inpatient stay is unlikely to confine itself to individuals with respiratory disease; as 202 
highlighted by negative impact of prolonged bed rest in general adult populations.
25,26
 203 
Therefore, the constraints of the hospital setting appear to be the key ceiling on PA rather 204 
than disease or behavioural constraints which would increase variability in activity levels and 205 
a gradual increase towards discharge. In the UK, pressures on bed capacity may have 206 
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contributed to present study observations because once a patient starts being more physically 207 
active, they may be discharged and their improvement not captured.  208 
The low day-to-day variation in step count meant that one day of at least 11 hours of PA data 209 
was sufficient to obtain a representative measure of the whole hospital stay whilst retaining 210 
sufficient sample size. In a study of individuals with stable COPD attending pulmonary 211 
rehabilitation, it was recommended that at least two days of step count data was required with 212 
variability plateauing at a minimum threshold of four days (n=57, SenseWear Pro Armband) 213 
based on an ICC >0.8.
16
 Similarly, in healthy adults, a minimum of two to six days has been 214 
suggested across wrist-worn GENEActiv-derived physical activity.
27
 The reduced variability 215 
in PA during hospitalisation in this study, compared with other studies of free-living data, 216 
confirms the need for specific inpatient PA criteria. Differences in how activity monitors 217 
determine wear time may also contribute, with the SWA using physiological sensing 218 
compared to sustained inactivity for physics-based devices. It does not matter how far into 219 
their hospital stay patients are when their PA is monitored but varying lengths of hospital stay 220 
between patients leads us to recommend measuring inpatient PA as soon as possible. 221 
Findings from the present study may help to reduce the patient burden of wearing an activity 222 
monitor when acutely unwell, allow measurements in patients with short admission durations 223 
and potentially enhance affordability and feasibility for researchers investigating PA in this 224 
setting. 225 
The pattern of inpatient PA observed over the course of the day in the present study was 226 
similar to individuals with stable respiratory disease.
16,28
 PA (stepping in the present study 227 
and metabolic equivalents in previous studies) peaked between 09:00 and 12:00. A secondary 228 
peak in hourly activity around 14:00 in this study was consistent with the stable disease 229 
literature
28,29
 despite the differences in the setting where the current measurements were 230 
made.  Patients in the present study were generally, confined to indoors with access to 231 
smaller spaces for movement, had a reduced number of activities of daily living to perform 232 
and were acutely unwell. The higher levels of activity earlier in the day may be the 233 
consequence of increasing fatigue as the day goes on, potentially coupled with investigatory 234 
measures conducted during typical working hours and visiting times (3-5pm and 6-8pm). It 235 
may also be that the habitual nature of free-living PA transfers to the hospital environment; 236 
albeit at a lower level.  237 
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Limitations of the present work should be considered. The SWA may not have been sensitive 238 
enough to detect all steps taken by patients, such as those taken at a walking speed 239 
<1.8km/hour, leading to an underestimation of step count.
30,31
 In addition, the SWA only 240 
permits data to be exported in 60-s epochs. Therefore, it was not appropriate to investigate 241 
time spent walking due to the forced assumption that participants were walking for each full 242 
minute; which is likely to lead to a significant overestimation. Future work should explore the 243 
impact of shorter epochs in order to provide more accurate outputs for time spent walking as 244 
well as provide additional insights into patterns of PA.
32
 Whilst most PA monitors follow the 245 
basic premise of measuring acceleration along one, two or three axes, differences in outputs 246 
exist between devices.
15
 However, the examination of step count in the present study offers 247 
the most transferrable findings and may be most appropriate for assessing the PA of 248 
hospitalised individuals. 249 
CONCLUSION 250 
In the largest reported cohort with objectively measured inpatient PA in patients admitted 251 
with an exacerbation of chronic respiratory disease, the volume of PA did not change as 252 
patients recover in hospital and the variability in step count was low. A minimum wear time 253 
criterion of 11 waking hours on any single inpatient day was representative of the entire 254 
hospital stay whilst retaining an acceptable proportion of the initial sample size. Whilst it 255 
does not matter how far into their hospital stay patients are when PA is measured, we suggest 256 
capturing this information as early as possible due to varying lengths of hospital stay. Length 257 
of hospital stay was not associated with inpatient PA. PA varied considerably within a typical 258 
day, with peaks of activity seen in the late morning and early afternoon. The processing and 259 
analysing methods presented here may have positive implications for study designs; 260 
potentially minimising participant burden and reducing costs for researchers. 261 
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TABLES 384 
Table 1 Participant characteristics, reported as mean (SD) unless otherwise stated. 385 
Descriptive variable All participants (N=259) 
Age (years) 70.0 (9.7) 
Gender (%): 
Male/ Female 
108 (42)/ 151 (58) 
BMI (kg/m
2
) 26.5 (7.2) 
Length of hospital stay (days) 5.4 (3.1) 
Primary diagnosis (%): 
COPD/ Chronic asthma/ ILD/ Bronchiectasis 
217 (84)/17 (7)/14 (5)/11 (4) 
FEV1 (L) 1.2 (0.6) 
FVC (L) 2.3 (0.8) 
FEV1/FVC  52.2 (17.6) 
FEV1 % predicted 54.7 (23.4) 
MRC grade at admission (%): 
3/4/5 
5 (2)/67 (26)/187 (72) 
MRC grade during stable disease (%): 
3/4/5 
74 (29)/124 (48)/58 (22) 
Smoking status (%): 
Never/ Former/ Current 
19 (7)/177 (68)/63 (24) 
NIV during hospital stay (%): 
Yes/ No 
12 (5)/247 (95) 
Oxygen during hospital stay (%): 
Yes/ No 
184 (71)/75 (29) 
Abbreviations: BMI, body mass index; COPD, chronic obstructive pulmonary disease; FEV1, 386 
forced expiratory volume in one second; FVC, forced vital capacity; ILD, interstitial lung 387 
disease; MRC, Medical Research Council; NIV, non-invasive ventilation  388 
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Table 2 Changes in step count per day during the inpatient stay, intraclass correlation 389 
coefficients and required number of days of activity monitoring in order to acquire 390 
representative data, across a range of minimum wear time criteria 391 
Wear 
time  
criteria 
N 
Step count  
(mean(95%CI)) ICCs 
Number 
of days 
needed 
A
 
Number 
of days 
needed 
B
 
Day  
2 
Day  
3 
Day  
4 
Day  
5 
Day  
6 
Day  
7 
   
≥5  
hours 
58 
605 
(443-766) 
622 
(446-798) 
663 
(481-846) 
642 
(487-798) 
707 
(519-895) 
659 
(494-823) 
0.834 0.80 1.0 
≥6  
hours 
56 
596 
(429-763) 
628 
(447-810) 
661 
(473-790) 
632 
(475-790) 
700 
(507-892) 
643 
(475-812) 
0.841 0.76 1.0 
≥7  
hours 
53 
625 
(451-798) 
658 
(469-846) 
688 
(492-884) 
661 
(497-824) 
734 
(535-934) 
678 
(505-852) 
0.835 0.79 1.0 
≥8  
hours 
53 
625 
(451-798) 
658 
(469-846) 
688 
(492-884) 
661 
(497-824) 
734 
(535-934) 
678 
(505-852) 
0.835 0.79 1.0 
≥9  
hours 
50 
599 
(425-773) 
655 
(456-855) 
674 
(466-881) 
612 
(449-775) 
707 
(499-915) 
654 
(472-836) 
0.854 0.68 1.0 
≥10  
hours 
49 
566 
(402-730) 
615 
(429-800) 
640 
(440-839) 
589 
(430-749) 
675 
(473-877) 
630 
(451-808) 
0.841 0.76 1.0 
≥11  
hours 
44 
585 
(404-767) 
646 
(441-851) 
676 
(457-895) 
613 
(437-788) 
704 
(483-925) 
668 
(472-864) 
0.839 0.77 1.0 
≥12  
hours 
41 
602 
(410-794) 
669 
(451-886) 
684 
(452-915) 
633 
(447-819) 
707 
(476-939) 
696 
(488-904) 
0.843 0.75 1.0 
Abbreviation: CI, confidence interval; ICCs, Intraclass correlation coefficient for single day 392 
of measurement 393 
N, number of participants with valid data for all days (days 2 through 7) 394 
A
, minimum number of days needed to achieve an ICC of 0.80 calculated using the 395 
Spearman-Brown prophecy formula; 
B
, estimates from the Spearman-Brown prophecy 396 
formula should be rounded up (e.g., an estimate of at least 2.3 days should be interpreted as at 397 
least 3.0 days because 2.0 days will not be sufficient to obtain an ICC ≥0.80  398 
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FIGURE CAPTIONS 399 
Figure 1 CONSORT flow diagram 400 
Figure 2 Step count between inpatient days using a minimum wear time of ≥11 hours. Data 401 
are reported as mean (95%CI) from all available valid days (White bars; Day 2: N=194; Day 402 
3: N=144; Day 4: N=107; Day 5: N=77; Day 6: N=63; Day 7: N=49) and from patients with 403 
valid data on all days (Grey bars; N=44). 404 
Figure 3 Step count per hour as a proportion of total daily step count across an average 24-405 
hour period using a minimum wear time of ≥11 hours; stratified by quarter of the day 406 
(overnight=00:00-05:59; morning=06:00-11:59; afternoon=12:00-17:59; evening=18:00-407 
23:59). Data are reported as mean (95%CI). 408 
 409 
